Fate Therapeutics IncNASDAQ:FATE
- LAST PRICE4.2400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.1100/ 1
- Ask / Lots4.7000/ 10
- Open / Previous Close0.0000 / 4.2400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FATE |
|---|---|---|
| 09:32 ET | 26249 | 4.47 |
| 09:34 ET | 23442 | 4.47 |
| 09:36 ET | 17711 | 4.4639 |
| 09:38 ET | 15195 | 4.47 |
| 09:39 ET | 16456 | 4.42 |
| 09:41 ET | 7008 | 4.425 |
| 09:43 ET | 9026 | 4.35 |
| 09:45 ET | 3999 | 4.38 |
| 09:48 ET | 2948 | 4.36 |
| 09:50 ET | 12536 | 4.36 |
| 09:52 ET | 5018 | 4.37 |
| 09:54 ET | 32027 | 4.365 |
| 09:56 ET | 4050 | 4.385 |
| 09:57 ET | 9050 | 4.405 |
| 09:59 ET | 4458 | 4.375 |
| 10:01 ET | 1748 | 4.335 |
| 10:03 ET | 6521 | 4.305 |
| 10:06 ET | 1354 | 4.29 |
| 10:08 ET | 867 | 4.28 |
| 10:10 ET | 8518 | 4.27 |
| 10:12 ET | 3018 | 4.23 |
| 10:14 ET | 8697 | 4.25 |
| 10:15 ET | 4165 | 4.2797 |
| 10:17 ET | 5049 | 4.23 |
| 10:19 ET | 2799 | 4.21 |
| 10:21 ET | 5444 | 4.22 |
| 10:24 ET | 3195 | 4.21 |
| 10:26 ET | 7428 | 4.2 |
| 10:28 ET | 10368 | 4.185 |
| 10:30 ET | 3045 | 4.185 |
| 10:32 ET | 3150 | 4.205 |
| 10:33 ET | 8273 | 4.25 |
| 10:35 ET | 8334 | 4.255 |
| 10:37 ET | 3981 | 4.22 |
| 10:39 ET | 4275 | 4.18 |
| 10:42 ET | 7250 | 4.215 |
| 10:44 ET | 19725 | 4.25 |
| 10:46 ET | 10025 | 4.225 |
| 10:48 ET | 1275 | 4.225 |
| 10:50 ET | 6080 | 4.235 |
| 10:51 ET | 5200 | 4.235 |
| 10:53 ET | 11645 | 4.24 |
| 10:55 ET | 10473 | 4.245 |
| 10:57 ET | 2732 | 4.245 |
| 11:00 ET | 4572 | 4.245 |
| 11:02 ET | 6044 | 4.275 |
| 11:04 ET | 9164 | 4.255 |
| 11:06 ET | 1100 | 4.26 |
| 11:08 ET | 16232 | 4.25 |
| 11:09 ET | 900 | 4.255 |
| 11:11 ET | 1578 | 4.25 |
| 11:13 ET | 3500 | 4.23 |
| 11:15 ET | 1279 | 4.2301 |
| 11:18 ET | 2632 | 4.225 |
| 11:20 ET | 3378 | 4.22 |
| 11:22 ET | 2753 | 4.215 |
| 11:24 ET | 5728 | 4.22 |
| 11:26 ET | 10044 | 4.255 |
| 11:27 ET | 5890 | 4.24 |
| 11:29 ET | 2326 | 4.245 |
| 11:31 ET | 11686 | 4.265 |
| 11:33 ET | 1300 | 4.265 |
| 11:36 ET | 2010 | 4.265 |
| 11:38 ET | 22465 | 4.285 |
| 11:40 ET | 13443 | 4.285 |
| 11:42 ET | 10714 | 4.275 |
| 11:44 ET | 1792 | 4.27 |
| 11:45 ET | 12770 | 4.26 |
| 11:47 ET | 900 | 4.26 |
| 11:49 ET | 5516 | 4.24 |
| 11:51 ET | 6438 | 4.24 |
| 11:54 ET | 5950 | 4.24 |
| 11:56 ET | 1900 | 4.25 |
| 11:58 ET | 6227 | 4.245 |
| 12:00 ET | 1594 | 4.255 |
| 12:02 ET | 5337 | 4.25 |
| 12:03 ET | 800 | 4.24 |
| 12:05 ET | 9494 | 4.245 |
| 12:07 ET | 5618 | 4.235 |
| 12:09 ET | 1415 | 4.24 |
| 12:12 ET | 12337 | 4.245 |
| 12:14 ET | 6105 | 4.235 |
| 12:16 ET | 3000 | 4.245 |
| 12:18 ET | 4256 | 4.23 |
| 12:20 ET | 5245 | 4.21 |
| 12:21 ET | 1137 | 4.215 |
| 12:23 ET | 4157 | 4.21 |
| 12:25 ET | 1887 | 4.215 |
| 12:27 ET | 7717 | 4.225 |
| 12:30 ET | 939 | 4.22 |
| 12:32 ET | 3553 | 4.21 |
| 12:34 ET | 5024 | 4.23 |
| 12:36 ET | 2394 | 4.23 |
| 12:38 ET | 3200 | 4.225 |
| 12:39 ET | 1900 | 4.225 |
| 12:41 ET | 13033 | 4.25 |
| 12:45 ET | 1200 | 4.255 |
| 12:48 ET | 700 | 4.255 |
| 12:50 ET | 1000 | 4.25 |
| 12:52 ET | 36921 | 4.29 |
| 12:54 ET | 100 | 4.29 |
| 12:56 ET | 836 | 4.285 |
| 12:57 ET | 25481 | 4.285 |
| 12:59 ET | 11878 | 4.275 |
| 01:01 ET | 348 | 4.27 |
| 01:03 ET | 5517 | 4.26 |
| 01:06 ET | 16915 | 4.265 |
| 01:08 ET | 1612 | 4.25 |
| 01:10 ET | 900 | 4.25 |
| 01:12 ET | 29532 | 4.265 |
| 01:14 ET | 400 | 4.26 |
| 01:15 ET | 1300 | 4.26 |
| 01:17 ET | 19630 | 4.27 |
| 01:19 ET | 1300 | 4.27 |
| 01:21 ET | 14983 | 4.265 |
| 01:24 ET | 239 | 4.27 |
| 01:26 ET | 900 | 4.275 |
| 01:28 ET | 8100 | 4.285 |
| 01:30 ET | 900 | 4.285 |
| 01:32 ET | 789 | 4.29 |
| 01:33 ET | 900 | 4.28 |
| 01:35 ET | 9399 | 4.275 |
| 01:37 ET | 1074 | 4.27 |
| 01:39 ET | 1528 | 4.27 |
| 01:42 ET | 3790 | 4.275 |
| 01:44 ET | 1044 | 4.27 |
| 01:46 ET | 8356 | 4.28 |
| 01:48 ET | 1243 | 4.2847 |
| 01:50 ET | 5189 | 4.275 |
| 01:51 ET | 7691 | 4.285 |
| 01:53 ET | 14929 | 4.255 |
| 01:55 ET | 1100 | 4.25 |
| 01:57 ET | 11195 | 4.235 |
| 02:00 ET | 1615 | 4.23 |
| 02:02 ET | 3826 | 4.23 |
| 02:04 ET | 2313 | 4.245 |
| 02:06 ET | 2983 | 4.23 |
| 02:08 ET | 600 | 4.23 |
| 02:09 ET | 1056 | 4.23 |
| 02:11 ET | 3362 | 4.225 |
| 02:13 ET | 2262 | 4.23 |
| 02:15 ET | 3228 | 4.23 |
| 02:18 ET | 4834 | 4.22 |
| 02:20 ET | 621 | 4.22 |
| 02:22 ET | 5099 | 4.225 |
| 02:24 ET | 1459 | 4.225 |
| 02:26 ET | 13374 | 4.22 |
| 02:27 ET | 661 | 4.23 |
| 02:29 ET | 897 | 4.22 |
| 02:31 ET | 8275 | 4.205 |
| 02:33 ET | 1792 | 4.2 |
| 02:36 ET | 2113 | 4.2 |
| 02:38 ET | 1478 | 4.2 |
| 02:40 ET | 2300 | 4.2 |
| 02:42 ET | 5693 | 4.195 |
| 02:44 ET | 27083 | 4.2 |
| 02:45 ET | 200 | 4.205 |
| 02:47 ET | 1475 | 4.2 |
| 02:49 ET | 3339 | 4.21 |
| 02:51 ET | 3878 | 4.22 |
| 02:54 ET | 2623 | 4.215 |
| 02:56 ET | 1600 | 4.21 |
| 02:58 ET | 12546 | 4.23 |
| 03:00 ET | 7589 | 4.215 |
| 03:02 ET | 6022 | 4.2 |
| 03:03 ET | 7772 | 4.225 |
| 03:05 ET | 1651 | 4.225 |
| 03:07 ET | 4582 | 4.215 |
| 03:09 ET | 4940 | 4.2 |
| 03:12 ET | 1857 | 4.195 |
| 03:14 ET | 7034 | 4.195 |
| 03:16 ET | 22084 | 4.215 |
| 03:18 ET | 846 | 4.215 |
| 03:20 ET | 2246 | 4.21 |
| 03:21 ET | 1929 | 4.21 |
| 03:23 ET | 2277 | 4.215 |
| 03:25 ET | 2074 | 4.21 |
| 03:27 ET | 9811 | 4.215 |
| 03:30 ET | 3062 | 4.205 |
| 03:32 ET | 1167 | 4.205 |
| 03:34 ET | 1778 | 4.205 |
| 03:36 ET | 2074 | 4.21 |
| 03:38 ET | 3394 | 4.205 |
| 03:39 ET | 9969 | 4.215 |
| 03:41 ET | 6825 | 4.21 |
| 03:43 ET | 3451 | 4.22 |
| 03:45 ET | 6073 | 4.22 |
| 03:48 ET | 7435 | 4.22 |
| 03:50 ET | 4957 | 4.21 |
| 03:52 ET | 15580 | 4.225 |
| 03:54 ET | 27683 | 4.21 |
| 03:56 ET | 38647 | 4.23 |
| 03:57 ET | 40881 | 4.225 |
| 03:59 ET | 326687 | 4.24 |
May 10, 2024
DJ Fate Therapeutics Is Maintained at Buy by Canaccord Genuity, from 2:48PM ET on Friday May 10, 2024 by Dow Jones
2:48PM ET on Friday May 10, 2024 by Dow JonesDJ Fate Therapeutics Is Maintained at Market Perform by BMO Capital, from 11:27AM ET on Friday May 10, 2024 by Dow Jones
11:27AM ET on Friday May 10, 2024 by Dow JonesDJ Fate Therapeutics Is Maintained at Neutral by Piper Sandler, from 9:28AM ET on Friday May 10, 2024 by Dow Jones
9:28AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
*DJ Fate Therapeutics 1Q Loss/Shr 47c >FATE, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow JonesFate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fate Therapeutics Inc | 482.6M | -2.2x | --- |
Editas Medicine Inc | 493.4M | -2.9x | --- |
ADC Therapeutics SA | 397.3M | -1.5x | --- |
Urogen Pharma Ltd | 497.9M | -4.1x | --- |
Poseida Therapeutics Inc | 335.4M | -2.5x | --- |
Contineum Therapeutics Inc | 400.5M | 16.9x | --- |
Company Information
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Contact Information
- Headquarters
- 12278 Scripps Summit DriveSAN DIEGO, CA, United States 92131
- Phone
- 858-875-1803
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- William Rastetter
- President, Chief Executive Officer, Director
- John Wolchko
- Independent Vice Chairman of the Board
- John Mendlein
- Chief Financial Officer
- Edward Dulac
- General Counsel and Corporate Secretary
- Cindy Tahl
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $482.6M |
|---|---|
Revenue (TTM) | $6.5M |
Shares Outstanding | 113.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.93 |
EPS | $-1.92 |
Book Value | $3.74 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 74.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,287.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
